CommercialCoverageLow impact
08.00.25o, Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents
Independence Blue Cross·Pulmonology, Cardiology, Critical Care·Pharmacy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
The policy for Treatment of Pulmonary Artery Hypertension with IV, subcutaneous, and inhaled medications has been reissued with an effective date of April 1, 2026. This is a reissue of an existing policy rather than new coverage criteria or requirements.
Action Required
Before April 1, 2026: Review the updated policy document at the provided URL to identify any changes in coverage criteria, prior authorization requirements, or documentation needs for pulmonary artery hypertension treatments. Update billing procedures and staff training as needed based on any identified changes.